APLM: Apollomics, Inc. Narx-foyda va o‘sish multiplikatori
Apollomics, Inc. (APLM) kam uchraydigan o'pka saratoni mutatsiyalariga e'tibor qaratadi va patentlar orqali foydani dumpingdan himoya qiladi. O'rtacha PEG koeffitsiyenti baholash va o'sish sur'atlari o'rtasidagi muvozanatni vizuallashtiradi, bunda 0.00 ushbu metrikaning joriy darajasini ifodalaydi. Kompaniyaning o'sishi webreltinibni tijoriyashtirishga asoslangan, biznes barqarorligi esa ventchura tuzilmasi va maqsadli terapiya sohasidagi global litsenziyalarga tayanadi.
Apollomics, Inc. (APLM) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Apollomics, Inc.|APLM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati apollomicsinc.com|APLM - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati Apollomics Corp|APLM - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Apollomics|Tezkor likvidlik apollomicsinc.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
APLM - Kompaniyaning sof foydasi|Kutilayotgan foyda Apollomics, Inc.|APLM - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati apollomicsinc.com|APLM - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Apollomics Corp|APLM - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Apollomics|APLM - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi apollomicsinc.com|APLM - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Apollomics, Inc.
Kompaniyaning fundamental tahlili:Apollomics Inc. - APLM
PEG koeffitsiyenti biznesning haddan tashqari qimmat yoki past baholanganligini aniqlash uchun aksiyaning bozor qiymatini uning foyda o'sish sur'ati bilan solishtiradi. Birga solishtirganda pastroq qiymatlar o'sish arzonligidan dalolat beradi, bu esa aktivni potentsial jozibador qiladi. Baholash va o'sish muvozanatining ushbu ko'rsatkichi tahlil qilinganda, investor tendentsiyaning barqarorligini aniqlaydi. Apollomics, Inc. (APLM) uchun bunday metrika klinik sinovlarga bog'liqligi sababli juda muhimdir. Geopolitik risklar va R&D xarajatlari ushbu ko'rsatkich dinamikasini buzishi mumkin.
Apollomics, Inc. raqobatchilari
ONC (BeiGene Ltd.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HALO (Halozyme Inc.)|RVMD - Narx-foyda va o‘sish multiplikatori|AAPG: Narx-foyda va o‘sish multiplikatori|CGON - PEG multiplikatori|UroGen Pharma (URGN) - Narxning foydaga va o‘sish sur’atiga nisbati|Bicara Therapeutics Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PSNL (Personalis Corp) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Erasca Oncology ERAS|PEG multiplikatori DCTH|PEG multiplikatori ymabs.com (YMAB)|Narxning foydaga va o‘sish sur’atiga nisbati Aura Biosciences AURA|CADL (Candel Therapeutics Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|ARAY - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda SELLAS Life Sciences|Actuate Therapeutics, Inc. (ACTU) - Narxning foydaga va o‘sish sur’atiga nisbati|CTOR (citiusonc.com) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati TuHURA Biosciences Inc.|Narxning foydaga va o‘sish sur’atiga nisbati TARA|Narxning foydaga va o‘sish sur’atiga nisbati Fate Therapeutics Corp (FATE)|WHWK - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati TScan Therapeutics, Inc. TCRX|CSBR - Narx-foyda va o‘sish multiplikatori|XBiotech USA - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati CEL-SCI Corporation CVM|OSTX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Radiopharm Theranostics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Artiva Biotherapeutics Inc.|Adlai Nortye Limited (ANL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori VERU (Veru)|TPST (Tempest Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori XLO (Xilio Therapeutics)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Renovaro Biosciences (RENB)|MURA - Narxning foydaga va o‘sish sur’atiga nisbati|KAPA (Kairos Pharma Ltd) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|OKUR: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CytoMed Therapeutics Limited|Narx-foyda va o‘sish multiplikatori CRIS|Tharimmune Corporation (THAR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori ADVB|PEG multiplikatori genprex.com (GNPX)|Narxning foydaga va o‘sish sur’atiga nisbati Calidi Biotherapeutics, Inc. CLDI|SBFM (Sunshine Biopharma Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|XBIO - Narxning foydaga va o‘sish sur’atiga nisbati|SLRX: Narxning foydaga va o‘sish sur’atiga nisbati|Purple Biotech (PPBT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori American Oncology Network, Inc.|BGNE (BeiGene) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Checkpoint Therapeutics Inc. (CKPT)|PEG multiplikatori ELEV|PEG multiplikatori icadmed.com (ICAD)|Narxning foydaga va o‘sish sur’atiga nisbati Ikena Oncology IKNA|NTBL: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Viracta - PEG multiplikatori|MorphoSys Inc (MOR) - Narx-foyda va o‘sish multiplikatori|NAYA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ascentage (AAPGV)
